Modified oligonucleotides--synthesis, properties and applications.
Lyer
R P
RP
OriGenix Technologies Inc, Laval, Quebec, Canada. kuttan50@hotmail.com
Roland
A
A
Zhou
W
W
Ghosh
K
K
D000577:Amides / Q000737:chemistry; D001896:Boron Compounds / Q000737:chemistry; D002241:Carbohydrates / Q000737:chemistry; D015195:Drug Design; D008968:Molecular Conformation; D015394:Molecular Structure; D009841:Oligonucleotides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D020135:Peptide Nucleic Acids / Q000138:chemical synthesis / Q000737:chemistry; D010756:Phosphoric Acids / Q000737:chemistry; D011687:Purines / Q000737:chemistry; D011743:Pyrimidines / Q000737:chemistry; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013873:Thionucleotides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology
D000577:Amides; D001896:Boron Compounds; D002241:Carbohydrates; D009841:Oligonucleotides; D020135:Peptide Nucleic Acids; D010756:Phosphoric Acids; D011687:Purines; D011743:Pyrimidines; D013873:Thionucleotides; C011067:phosphoramidic acid